We have taken the initiative and intensified outpatient study implementation in the field of oncology in order to make new therapy options available for as many patients as possible. Together with our Oncology Strategy Board, we want to sustainably promote outpatient oncology trials in Germany. Our Oncology Strategy Board Meeting enables us to regularly exchange experiences between all colleagues, specialists and experts from the field of clinical research and industry.
You can find out what we have already achieved in the news section.
Here you will find an overview of the members of the Oncology Strategy Board with brief information on their medical expertise and career.